Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05880914 · ClinicalTrials.gov registry record
Precision Medicine Approaches to Renal Osteodystrophy
A clinical trial of Chronic Kidney Diseases and Secondary Hyperparathyroidism, sponsored by Thomas Nickolas.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT05880914 is a study of Chronic Kidney Diseases and Secondary Hyperparathyroidism that is actively recruiting participants, run by Thomas Nickolas. The registered enrollment target is 40 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05880914, a study of Chronic Kidney Diseases and Secondary Hyperparathyroidism, is actively recruiting participants, sponsored by Thomas Nickolas.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Treatment of renal osteodystrophy is impeded by the lack of practical and accurate tools to determine underlying bone turnover. Gold standard bone biopsy is not practical in the clinic for the vast majority of kidney disease patients and parathyroid hormone and bone alkaline phosphatase have insufficient accuracy for turnover type to safely and confidently guide treatment of renal osteodystrophy. In the present investigation, the investigators will study a microRNA approach as a novel non-invasive biomarker of turnover for renal osteodystrophy.
Conditions Studied
Interventions
- PROCEDURE miRNAseq analysis
- DRUG Standard treatment for bone disorder
Study Locations (1)
Missouri
- Washington University in St. Louis (WashU) - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-12-21 |
| Est. Completion | 2027-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05880914
The ClinicalTrials.gov registry entry for NCT05880914 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (91% lower). The listed sponsor is Thomas Nickolas, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 2 interventions - of which miRNAseq analysis is the first listed.
NCT05880914 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT05880914 about?
NCT05880914 is a clinical study titled "Precision Medicine Approaches to Renal Osteodystrophy". Treatment of renal osteodystrophy is impeded by the lack of practical and accurate tools to determine underlying bone turnover. Gold standard bone biopsy is not practical in the clinic for the vast majority of kidney disease patients and parathyroid hormone and bone alkaline phosphatase have insuffi...
What is the current status of trial NCT05880914?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2022-12-21. Estimated completion is 2027-06-30.
What conditions does trial NCT05880914 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Secondary Hyperparathyroidism, Renal Osteodystrophy, CKD-MBD, Bone Turnover Rate Disorder.
What interventions are being tested in trial NCT05880914?
The interventions under investigation include: miRNAseq analysis (PROCEDURE), Standard treatment for bone disorder (DRUG).
Who is sponsoring clinical trial NCT05880914?
This trial is sponsored by Thomas Nickolas, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05880914 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
RECRUITING · Phase 2
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Ferric Citrate and Chronic Kidney Disease in Children
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.